Therapeutic Potential of Stem Cells in Neurodegenerative Diseases
49
TABLE 2.1
How various stem cell types are utilized in neurodegenerative disease
research
Activity
Purpose
Stem cell type
Clinical research Cell therapy and transplantation
ESCs, iPSCs
Neuroprotective effects
MSCs
Modulation of
neuroinflammation and immune
responses
MSCs, HSCs
Basic and
translational
research
Neurodegenerative disease
modeling
ESCs, iPSCs
Drug screening
ESCs, iPSCs
Understanding neurogenesis and
neuronal pathways
NSCs, ESCs, iPSCs
Activation of neurogenesis and
promotion neuroregeneration
NSCs, iPSCs
of new strategies and potential
therapeutic targets in vitro/vivo
Various
Neurotrophic effects
MSCs
Brain organoids/spheroids
iPSCs, ESCs
The application of certain stem cell types in research activities related
to widespread neurodegenerative diseases is discussed in more detail in the
following titles.
2.3.1
Alzheimer’s Disease (AD)
Alzheimer’s disease (AD) is the leading dementia-causing brain pathology,
with a rapid increase of approximately 148% in the aging population [34, 35].
AD is characterized by extracellular plaque formation and the accumulation of
intracellular neurofibrillary tangles that impede brain functions, particularly
memory, cognition, and learning. According to the well-accepted pathogenic
mechanism, amyloid β-peptide (Aβ) is formed as a result of faulty proteolytic
cleavage of amyloid precursor protein (APP), a transmembrane protein on
nerve cells. Polymerized amphipathic Aβ molecules occupy synaptic space
as insoluble amyloid plaques, which disrupt synaptic signaling [36, 37]. In
parallel, Aβ accumulation causes hyperphosphorylation of tau protein, which
normally stabilizes microtubules for a proper axonal process. This abnormal
hyperphosphorylation state disrupts conformation and leads to misfolding in
tau protein [38, 39]. Aberrant tau proteins aggregate as insoluble neurofibril-
lary tangles (NFTs) inside the neurons [39, 40]. Eventually, Aβ and tau de-
position together results in neuroinflammation and neurotoxicity within the
brain. While dominant inheritance of the mutations in three major genes (amy-
loid precursor protein (APP) gene, presenilin1 (PSEN1) gene, and presenilin